Defense Threat Reduction Agency Awards Biomimetic Contract

March 21, 2013
George I. Seffers
E-mail About the Author

Sanofi Pasteur VaxDesign Corporation, Orlando, Fla., is being awarded a $15,106,789 cost-plus fixed-fee, incrementally-funded contract for research and development services for the Defense Threat Reduction Agency (DTRA) to further optimize and utilize the invitro biomimetic immune system. The contract award was a direct response to DTRA's Chem-Bio Broad Agency Announcement. The contracting activity is Defense Threat Reduction Agency, Fort Belvoir, Va.

Enjoyed this article? SUBSCRIBE NOW to keep the content flowing.